2 
1 (b) the knowledge gained from such research and 
2 other activities may be of great benefit to medicine and 
3 agriculture and may provide many other benefits to 
4 society ; 
5 (c) uncertainties ekist regarding the extent to which 
6 organisms or viruses containing recombinant DNA may 
7 present a risk of injury to health or the environment, 
8 and there is a risk that any such potentially hazardous 
9 5 organisms or viruses may spread quickly and without 
10 \> warning to persons, agricultural plants and products, 
11 v and other items in or affecting commerce ; 
12 (d) the public interest ’requires that until the un- 
13 1 certainties regarding the potential hazards of organisms 
14 and viruses containing recombinant DXA are resolved, 
15 ; sthe health and welfare of the population of the United 
16 States be protected from such hazards, and commerce 
17 ' in the United States is dependent upon such protection 
18 being provided ; and 
19 (e) to effectively accomplish such protection and 
20 consequently to effectively regulate commerce requires 
21 that any activity involving organisms or viruses contain- 
22 ing recombinant DXA (whether a research or commer- 
23 cial activity) be subject to control. 
[Appendix B — 26] 
